Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Entresto
Pharma
Novartis asks court for swift decision in Entresto patent case
In its ongoing bid to stall the launch of MSN's proposed Entresto generic, Novartis has told a federal judge in Delaware that time is of the essence.
Fraiser Kansteiner
Jun 6, 2025 10:26am
A closer look at pharma’s top patent losses in 2025
Mar 21, 2025 9:00am
Novartis to lay off 427 staffers amid marketing model rework
Mar 18, 2025 10:19am
The top 10 drugs losing US exclusivity in 2025
Mar 17, 2025 3:00am
Novartis wins 11th-hour bid to block Entresto generic from MSN
Jan 17, 2025 11:41am
ICER calls out drugmakers over 'unsupported' price hikes
Dec 12, 2024 2:24pm
